相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IL-33 amplifies an innate immune response in the degenerating retina
Hongkang Xi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Interleukin 33 is a guardian of barriers and a local alarmin
Nikolas T. Martin et al.
NATURE IMMUNOLOGY (2016)
IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline
Amy K. Y. Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
IL-4 Regulates Specific Arg-1(+) Macrophage sFlt-1-Mediated Inhibition of Angiogenesis
Wei-Kang Wu et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Red Blood Cells Store and Release Interleukin-33
Jianxin Wei et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2015)
Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33
Wei-Yu Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
GEOGRAPHIC ATROPHY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Luna Xu et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
IL-18 Immunotherapy for Neovascular AMD: Tolerability and Efficacy in Nonhuman Primates
Sarah L. Doyle et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Immune Responses in Age-Related Macular Degeneration and a Possible Long-term Therapeutic Strategy for Prevention
Robert B. Nussenblatt et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2014)
IL-33 attenuates the development of experimental autoimmune uveitis
Mark Barbour et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
IL-18: a new player in immunotherapy for age-related macular degeneration?
Matthew Campbell et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells
Rahul Kakkar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33-LacZ Gene Trap Reporter Strain
Melanie Pichery et al.
JOURNAL OF IMMUNOLOGY (2012)
NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components
Sarah L. Doyle et al.
NATURE MEDICINE (2012)
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Emma Lefrancais et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Interleukin-1β Inhibition Prevents Choroidal Neovascularization and Does Not Exacerbate Photoreceptor Degeneration
Sophie Lavalette et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Interleukin-33 Induces Expression of Adhesion Molecules and Inflammatory Activation in Human Endothelial Cells and in Human Atherosclerotic Plaques
Svitlana Demyanets et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Emerging inflammasome effector mechanisms
Mohamed Lamkanfi
NATURE REVIEWS IMMUNOLOGY (2011)
IL-33 is a crucial amplifier of innate rather than acquired immunity
Keisuke Oboki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Disease-associated functions of IL-33: the new kid in the IL-1 family
Foo Y. Liew et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Forecasting Age-Related Macular Degeneration Through the Year 2050 The Potential Impact of New Treatments
David B. Rein et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production
Yeon-Sook Choi et al.
BLOOD (2009)
Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Alexander U. Luethi et al.
IMMUNITY (2009)
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Corinne Cayrol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Para-inflammation in the aging retina
Heping Xu et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2009)
Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation
Axel M. Kuchler et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Immune privilege or privileged immunity?
J. V. Forrester et al.
MUCOSAL IMMUNOLOGY (2008)
IL-33 exacerbates antigen-induced arthritis by activating mast cells
Damo Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Characterization of a spontaneous mouse retinal pigment epithelial cell line B6-RPE07
Mei Chen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells
Zouna Allakhverdi et al.
JOURNAL OF IMMUNOLOGY (2007)
IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex
Alissa A. Chackerian et al.
JOURNAL OF IMMUNOLOGY (2007)
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
Virginie Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Fibrosis and diseases of the eye
Martin Friedlander
JOURNAL OF CLINICAL INVESTIGATION (2007)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
A novel therapy of murine collagen-induced arthritis with soluble T1/ST2
BP Leung et al.
JOURNAL OF IMMUNOLOGY (2004)
Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro
JT Daniels et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
分享论文
